1. Home
  2. CVKD vs SBFM Comparison

CVKD vs SBFM Comparison

Compare CVKD & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • SBFM
  • Stock Information
  • Founded
  • CVKD 2022
  • SBFM 2006
  • Country
  • CVKD United States
  • SBFM Canada
  • Employees
  • CVKD N/A
  • SBFM N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • SBFM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CVKD Health Care
  • SBFM Health Care
  • Exchange
  • CVKD Nasdaq
  • SBFM Nasdaq
  • Market Cap
  • CVKD 8.2M
  • SBFM 6.3M
  • IPO Year
  • CVKD 2023
  • SBFM N/A
  • Fundamental
  • Price
  • CVKD $0.43
  • SBFM $0.30
  • Analyst Decision
  • CVKD Strong Buy
  • SBFM Strong Buy
  • Analyst Count
  • CVKD 2
  • SBFM 1
  • Target Price
  • CVKD $3.50
  • SBFM $260.00
  • AVG Volume (30 Days)
  • CVKD 71.0K
  • SBFM 1.5M
  • Earning Date
  • CVKD 08-12-2024
  • SBFM 08-08-2024
  • Dividend Yield
  • CVKD N/A
  • SBFM N/A
  • EPS Growth
  • CVKD N/A
  • SBFM N/A
  • EPS
  • CVKD N/A
  • SBFM N/A
  • Revenue
  • CVKD N/A
  • SBFM $26,739,780.00
  • Revenue This Year
  • CVKD N/A
  • SBFM $87.97
  • Revenue Next Year
  • CVKD N/A
  • SBFM $125.23
  • P/E Ratio
  • CVKD N/A
  • SBFM N/A
  • Revenue Growth
  • CVKD N/A
  • SBFM 193.30
  • 52 Week Low
  • CVKD $0.36
  • SBFM $0.28
  • 52 Week High
  • CVKD $2.17
  • SBFM $64.50
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 40.40
  • SBFM 34.50
  • Support Level
  • CVKD $0.43
  • SBFM $0.30
  • Resistance Level
  • CVKD $0.49
  • SBFM $0.35
  • Average True Range (ATR)
  • CVKD 0.02
  • SBFM 0.03
  • MACD
  • CVKD -0.00
  • SBFM 0.03
  • Stochastic Oscillator
  • CVKD 2.50
  • SBFM 14.93

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

Share on Social Networks: